Intranasal ipratropium bromide for the common cold

  • Protocol
  • Intervention

Authors

  • Zaina H AlBalawi,

    Corresponding author
    1. College of Medicine, King Saud University, Sheikh Abdullah S. Bahamdan Research Chair for Evidence-Based Health Care and Knowledge Translation, Riyadh, Central, Saudi Arabia
    • Zaina H AlBalawi, Sheikh Abdullah S. Bahamdan Research Chair for Evidence-Based Health Care and Knowledge Translation, College of Medicine, King Saud University, P.O. Box 68639, Riyadh, Central, 11537, Saudi Arabia. Zaina7rb@yahoo.com. zalbalaw@ualberta.ca.

    Search for more papers by this author
  • Sahar S Othman,

    1. College of Medicine, King Khalid University Hospital, Department of Internal Medicine, Riyadh, Central, Saudi Arabia
    Search for more papers by this author
  • Khalid AlFaleh

    1. King Saud University, Department of Pediatrics (Division of Neonatology), Riyadh, Saudi Arabia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To determine the effect of intranasal IB improvement on improvement of common cold symptoms, mainly rhinorrhoea and nasal congestion.

  2. To assess adverse effects resulting from use of intranasal IB for common cold (for example, dry mucous membranes, epistaxis, and systemic anticholinergic effects).